Treatments & Interventions
Sumatriptan succinate
substance
Naratriptan hydrochloride
substance
Rizatriptan benzoate
substance
Almotriptan malate
substance
Almotriptan
substance
Naratriptan
substance
Rizatriptan
substance
Zolmitriptan
substance
Frovatriptan succinate
substance
Dihydroergotamine
substance
Sumatriptan
substance
Ergotamine
substance
Ergotamine tartrate
substance
Eletriptan
substance
Frovatriptan
substance
Eletriptan hydrobromide
substance
OnabotulinumtoxinA
substance
Ubrogepant
substance
Rimegepant
substance
Rimegepant sulfate
substance
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Related Conditions
Quick Facts
- SNOMED CT
- 37796009
- UMLS CUI
- C0149931
- Fully Specified Name
- Migraine (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 6
- Known Treatments
- 20
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.